Preoperative versus postoperative chemoradiotherapy for rectal cancer.
By R. Sauer, H. Becker, W. Hohenberger, C. Rödel, C. Wittekind, R. Fietkau, P. Martus, J. Tschmelitsch, E. Hager, C. Hess and 4 more. New England Journal of Medicine, 2004
5,653 citations recorded by the source corpus.
Subfields: Obstetrics and Gynecology, Oncology, Surgery
View Paper: https://www.semanticscholar.org/paper/ad51ba8b6c2c36abc91d6b7a3528a57aee1d4eda
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
Citations in the corpus
- The Applications of Radiomics in Precision Diagnosis and Treatment of Oncology: Opportunities and Challenges (2019, methodology): “Although treatment may improve survival, it has not proven to improve the DFS of patients with locally advanced rectal cancer [13, 173, 174].”
- The TME Trial After a Median Follow-up of 6 Years: Increased Local Control But No Survival Benefit in Irradiated Patients With Resectable Rectal Carcinoma (2007, result): “80).(23) Although trial results should be compared with care due to differences in case mix, it has to be noted that survival rates in the German study appear more favorable, despite the advanced stage of disease at presentation.”
- Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2017, positive): “0 Gy/fraction) or SCPRT has better outcomes than postoperative CRT [87, 88].”
- Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study (2006, background): “…the optimal surgical technique of total mesorectal excision can cure early stage localised rectal cancer, 3 4 it is now evident that preoperative radiotherapy or chemoradiotherapy 5 may facilitate successful surgical excision and therefore improve outcome in patients with more extensive disease.”